AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma
Authors: Robnett, TJ Machtay, M Stevenson, JP Algazy, KM Hahn, SM
Citation: Tj. Robnett et al., Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma, J CL ONCOL, 19(5), 2001, pp. 1344-1349
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma ofthe head and neck
Authors: Rosenthal, DI Lee, JH Sinard, R Yardley, DA Machtay, M Rosen, DM Egorin, MJ Weber, RS Weinstein, GS Chalian, AA Miller, LK Frenkel, EP Carbone, DP
Citation: Di. Rosenthal et al., Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma ofthe head and neck, J CL ONCOL, 19(5), 2001, pp. 1363-1373
Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma
Authors: Machtay, M Lee, JH Shrager, JB Kaiser, LR Glatstein, E
Citation: M. Machtay et al., Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma, J CL ONCOL, 19(19), 2001, pp. 3912-3917
Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography
Authors: Li, PY Zhuang, HM Mozley, PD Denittis, A Yeh, D Machtay, M Smith, R Alavi, A
Citation: Py. Li et al., Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography, CLIN NUCL M, 26(2), 2001, pp. 131-135
RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck
Authors: Spencer, SA Harris, J Wheeler, RH Machtay, M Schultz, C Spanos, W Rotman, M Meredith, R
Citation: Sa. Spencer et al., RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck, INT J RAD O, 51(5), 2001, pp. 1299-1304
Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
Authors: Pilepich, MV Winter, K John, MJ Mesic, JB Sause, W Rubin, P Lawton, C Machtay, M Grignon, D
Citation: Mv. Pilepich et al., Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, INT J RAD O, 50(5), 2001, pp. 1243-1252
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
Authors: Lawton, CA Winter, K Murray, K Machtay, M Mesic, JB Hanks, GE Coughlin, CT Pilepich, MV
Citation: Ca. Lawton et al., Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate, INT J RAD O, 49(4), 2001, pp. 937-946
Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy
Authors: Horwitz, EM Winter, K Hanks, GE Lawton, CA Russell, AH Machtay, M
Citation: Em. Horwitz et al., Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy, INT J RAD O, 49(4), 2001, pp. 947-956
Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: Oncologic outcome and functional assessment
Authors: DeNittis, AS Machtay, M Rosenthal, DI Sanfilippo, NJ Lee, JH Goldfeder, S Chalian, AA Weinstein, GS Weber, RS
Citation: As. Denittis et al., Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: Oncologic outcome and functional assessment, AM J OTOLAR, 22(5), 2001, pp. 329-335
Radiotherapy with 6-megavolt photons for early glottic carcinoma: Potential impact of extension to the posterior vocal cord
Authors: Lee, JH Machtay, M McKenna, MG Weinstein, GS Markiewicz, DA Krisch, RE Kligerman, MM
Citation: Jh. Lee et al., Radiotherapy with 6-megavolt photons for early glottic carcinoma: Potential impact of extension to the posterior vocal cord, AM J OTOLAR, 22(1), 2001, pp. 43-54
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
Authors: Robnett, TJ Machtay, M Vines, EF McKenna, MG Algazy, KM McKenna, WG
Citation: Tj. Robnett et al., Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer, INT J RAD O, 48(1), 2000, pp. 89-94
Is prolonged survival possible for patients with supraclavicular node metastases in NSCLC treated with chemoradiotherapy? IJROBP 1999;44(4): 847-853 - Reply
Authors: Machtay, M Seiferheld, W
Citation: M. Machtay et W. Seiferheld, Is prolonged survival possible for patients with supraclavicular node metastases in NSCLC treated with chemoradiotherapy? IJROBP 1999;44(4): 847-853 - Reply, INT J RAD O, 46(4), 2000, pp. 1080-1081
Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma
Authors: Machtay, M Rosenthal, DI Algazy, KM Aviles, VM Chalian, AA Hershock, D Neubauer, R Greenberg, MJ Mirza, N Weinstein, GS Weber, RS
Citation: M. Machtay et al., Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma, AM J CL ONC, 23(5), 2000, pp. 509-515
Morbidity after midline mandibulotomy and radiation therapy
Authors: Eisen, MD Weinstein, GS Chalian, A Machtay, M Kent, K Coia, LR Weber, RS
Citation: Md. Eisen et al., Morbidity after midline mandibulotomy and radiation therapy, AM J OTOLAR, 21(5), 2000, pp. 312-317
Reality and meta-analyses
Authors: Machtay, M Kaiser, LR Glatstein, E
Citation: M. Machtay et al., Reality and meta-analyses, CHEST, 118(3), 2000, pp. 835-836
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer
Authors: Canaday, DJ Regine, WF Mohiuddin, M Zollinger, W Machtay, M Lee, J Schultz, D Rudoltz, MS
Citation: Dj. Canaday et al., Significance of pretreatment hemoglobin level in patients with T1 glottic cancer, RADIAT ON I, 7(1), 1999, pp. 42-48
Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers
Authors: Dowell, JE Sinard, R Yardley, DA Aviles, V Machtay, M Weber, RS Weinstein, GS Chalian, AA Carbone, DP Rosenthal, DI
Citation: Je. Dowell et al., Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers, SEM RAD ONC, 9(2), 1999, pp. 97-101
Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience
Authors: Machtay, M Seiferheld, W Komaki, R Cox, JD Sause, WT Byhardt, RW
Citation: M. Machtay et al., Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience, INT J RAD O, 44(4), 1999, pp. 847-853
A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy for unresectable head and neck cancer
Authors: Machtay, M Aviles, V Kligerman, MM Treat, J Weinstein, GS Weber, RS Mirza, N Chalian, AA Rosenthal, DI
Citation: M. Machtay et al., A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy for unresectable head and neck cancer, INT J RAD O, 44(2), 1999, pp. 311-315
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
Authors: Hustinx, R Smith, RJ Benard, F Rosenthal, DI Machtay, M Farber, LA Alavi, A
Citation: R. Hustinx et al., Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck, EUR J NUCL, 26(10), 1999, pp. 1345-1348
Lung and aero-digestive cancers in young marijuana smokers
Authors: Fung, M Gallagher, C Machtay, M
Citation: M. Fung et al., Lung and aero-digestive cancers in young marijuana smokers, TUMORI, 85(2), 1999, pp. 140-142
Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy
Authors: Lee, JH Machtay, M Kaiser, LR Friedberg, JS Hahn, SM McKenna, MG McKenna, WG
Citation: Jh. Lee et al., Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy, RADIOLOGY, 213(3), 1999, pp. 845-852
Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-F-18-fluoro-2-deoxy-D-glucose positron emission tomography
Authors: Farber, LA Benard, F Machtay, M Smith, RJ Weber, RS Weinstein, GS Chalian, AA Alavi, A Rosenthal, DI
Citation: La. Farber et al., Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-F-18-fluoro-2-deoxy-D-glucose positron emission tomography, LARYNGOSCOP, 109(6), 1999, pp. 970-975
Is meta-analysis really meta-physics?
Authors: Machtay, M Kaiser, LR Glatstein, E
Citation: M. Machtay et al., Is meta-analysis really meta-physics?, CHEST, 116(2), 1999, pp. 539-542
Malignant mesothelioma
Authors: Singhal, S Machtay, M Kaiser, LR
Citation: S. Singhal et al., Malignant mesothelioma, BAS CLIN ON, 20, 1999, pp. 477-523
Risultati: 1-25 | 26-26